Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,482) with videos related to
Page
of 149
Sort By:
Pathogens & Immunity
|
February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture Conversion
Maja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The New England Journal of Medicine
|
May 30, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLL
Nitin Jain, Michael Keating, Philip Thompson, et al.
Cancer Immunology Research
|
June 7, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N Desai, Bofei Wang, Andre Fonseca, et al.
Cancer Immunology Research
|
May 10, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N Desai, Bofei Wang, Andre Fonseca, et al.
Leukemia
|
July 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy
Alexandre Bazinet, Sanam Loghavi, Yue Wei, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
Nature Communications
|
July 12, 2018
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
Koichi Takahashi, Feng Wang, Kiyomi Morita, et al.
Trials
|
October 4, 2023
Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
Andrew R DiNardo, Moshe Arditi, Ashish M Kamat, et al.
American Journal of Hematology
|
April 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Alex Bataller, Alexandre Bazinet, et al.
Page
of 149
Search research articles
Search
Showing results (1091-1100 of 1,482) with videos related to
Sort By:
Page
of 149
Pathogens & Immunity
|
February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture Conversion
Maja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The New England Journal of Medicine
|
May 30, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLL
Nitin Jain, Michael Keating, Philip Thompson, et al.
Cancer Immunology Research
|
June 7, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N Desai, Bofei Wang, Andre Fonseca, et al.
Cancer Immunology Research
|
May 10, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N Desai, Bofei Wang, Andre Fonseca, et al.
Leukemia
|
July 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy
Alexandre Bazinet, Sanam Loghavi, Yue Wei, et al.
The New England Journal of Medicine
|
August 14, 2020
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
Nature Communications
|
July 12, 2018
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
Koichi Takahashi, Feng Wang, Kiyomi Morita, et al.
Trials
|
October 4, 2023
Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
Andrew R DiNardo, Moshe Arditi, Ashish M Kamat, et al.
American Journal of Hematology
|
April 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Alex Bataller, Alexandre Bazinet, et al.
Page
of 149